Delivery Order SPE2DR25D2205-SPE2DR26F1V03
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $82,443.45 to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 7, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,213.21 delivery order contract to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $28,181.63 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026. The contractor will perform from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,701.90 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside contract with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent organization, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $5,685.12 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent...
- The Defense Logistics Agency awarded a $13,575.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on January 12, 2026, with completion targeted for January 13, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $9,392.18 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Arimidex 1 mg tablets (30-count packages). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,337.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Arimidex 1 mg tablets, with a completion deadline of December 9, 2025. This non-set-aside competitive award reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract valued at $49,344.60, with an ultimate completion date of January 5, 2026. This competitive award, issued on January 2, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $7,057.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with a completion deadline of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1V03Delivery Order
The Defense Logistics Agency awarded a $33,960.54 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Arimidex 1 mg tablets (30-count packaging). This firm fixed-price contract, with an ultimate completion date of January 15, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical supply chains, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its proficiency in delivering a comprehensive range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This delivery order for Arimidex—an aromatase inhibitor used in breast cancer treatment—exemplifies the type of specialty pharmaceutical commodities the contractor routinely provides through its established DLA vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 1/13/26 |